Shock

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Proveca Pharma
Proveca PharmaUK - Manchester
1 program
1
DobutaminePhase 1/21 trial
Active Trials
NCT03311178TerminatedEst. Oct 2017
Zoll
ZollCA - San Jose
1 program
Full SWOT ModelN/A1 trial
Active Trials
NCT05073354CompletedEst. Apr 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Proveca PharmaDobutamine
ZollFull SWOT Model

Clinical Trials (2)

NCT03311178Proveca PharmaDobutamine

Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period

Start: May 2014Est. completion: Oct 2017
Phase 1/2Terminated
NCT05073354ZollFull SWOT Model

Rapid Treatment of Shock Without Trauma

Start: Jun 2021Est. completion: Apr 2024
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space